
Eris Lifesciences Limited has informed the Exchange regarding a press release dated November 08, 2023, titled "Eris announces the acquisition of Nephrology and Dermatology Branded Formulations business units of Biocon Biologics in India".
Filed with NSE ·

Eris Lifesciences Limited has informed the Exchange regarding a press release dated November 08, 2023, titled "Eris announces the acquisition of Nephrology and Dermatology Branded Formulations business units of Biocon Biologics in India".
6ix hasn’t read this filing yet.
Follow Eris Lifesciences into a list and get an email when it puts out news.
Follow Eris Lifesciences